Jérémie Meyer, Author at BaseLaunch

Scientist in a Lab Coat looking at Laboratory samples

All Features

News bulletin: CSL Behring becomes BaseLaunch partner for Phase II

We are very pleased to welcome CSL Behring, one of the largest biotech companies in the world, as a partner in BaseLaunch Phase II. Read the…

Jérémie Meyer30.07.2020

All Features

Bridge Biotherapeutics becomes BaseLaunch’s first Asia Pacific partner

Special Report: The latest addition to the partner portfolio all the way from Asia Pacific. A warm welcome to Bridge Biotherapeutics, for which CEO, James Lee,…

Jérémie Meyer14.07.2020

All Features

News flash: Roivant Sciences continues partnership

We welcome back Roivant Sciences with open arms for the continuation of their partnership with BaseLaunch Phase II. Sascha Bucher, Head of Global Transactions at…

Jérémie Meyer24.06.2020

All Portfolio news

New partner announcement: BB Pureos Bioventures

We are proud to announce that BB Pureos Bioventures has become a partner in BaseLaunch Phase II as the first venture capital fund. Anja Harmeier,…

Jérémie Meyer08.06.2020

All Features

Roche becomes a founding partner of BaseLaunch Phase II

We are proud to announce that Roche has become a founding partner in the next phase of BaseLaunch. With this commitment, Roche renews its partnership…

Jérémie Meyer15.05.2020

All Portfolio news

Polyneuron recieves approval to begin clinical study

Congratulations to one of BaseLaunch’s portfolio companies, Polyneuron on their latest milestone: First clinical trial application approval. Wishing you great success with the studies later…

Jérémie Meyer11.05.2020

All Features

Research Study Opportunity

There is an opportunity to participate in a research study interview taking place for those with knowledge of the biopharmaceutical industry in Switzerland. The research should…

Jérémie Meyer11.05.2020

All Features

Looking for people for exciting projects

We are supporting an exciting project that exploits the role and vulnerabilities of circulating tumor cell clusters, major mediators of metastasis. The team is developing…

Jérémie Meyer11.05.2020

All Features

Basic biotech starter kit: a flourishing ecosystem and highly focused support

“Go start a biotech company in a strong biotech ecosystem” is our conclusion from this Nature paper, which tracks down every biotech start-up emerging (between…

Jérémie Meyer08.05.2020